Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Maryland for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Maryland only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Maryland (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Gayatri Reilly (NPI 1174718456)

Field	Value
Entity Type	Individual
Organization	Gayatri Reilly
Address	5454 Wisconsin Ave Ste 650
City	Chevy Chase
State	MD
ZIP	20815
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	September 11, 2007

Payer Source	Total Paid
Medicare	$4.1M
Medicaid	$0

Key Findings

This provider is effectively a Medicare-focused retina specialist: Total Medicare revenue reported is $4.1M while there is no Medicaid billing on file, so operational scale and payer exposure are concentrated entirely in Medicare. The absence of Medicaid activity indicates the provider’s commercial mix and access dynamics will need to be evaluated outside of state-program volumes.

Revenue is highly concentrated in a small set of injection and evaluation codes — the precomputed top 3 Medicare codes by revenue account for 76.2% of this provider's total Medicare revenue. The single largest contributor is J0178 (Injection, aflibercept) at $2.5M and 61.0% of Medicare revenue, followed by 92014 ($359.8K, 8.8%) and J2777 ($264.5K, 6.4%), indicating dependence on anti-VEGF/ophthalmic injection services.

Clinical/service-line mix supports an office-based, procedure-driven retina practice focused on intravitreal pharmacologic therapy and high-volume follow-up evaluations. High revenue from J0178 and J2777 (aflibercept and faricimab) plus substantial claims for intravitreal injection procedure 67028 ($220.1K, 5.4%) and injection/implant codes such as J7312 ($77.9K) point to a workflow centered on repeated in-office injections, while large volume E/M code 92014 ($359.8K) reflects regular established-patient follow-up visits.

Competitive standing for key codes shows national-level prominence in several areas: J0178 ranks #94 of 3204 providers nationally (97th percentile; notably above typical national volume), 92014 ranks #34 of 35415 providers (100th percentile; extreme outlier), and 92134 (retinal OCT) ranks #225 of 26868 providers (99th percentile; extreme outlier). These rank/percentile positions indicate the provider operates at a much higher-than-typical national volume for core retina imaging and follow-up evaluation codes, and is a major national participant for aflibercept administration.

Not all high-revenue items are extreme outliers: J2777 (faricimab) generated $264.5K (6.4% of Medicare revenue) and ranks #1069 of 2039 providers (47th percentile; typical, unremarkable volume), while J3590 (unclassified biologics) contributed $237.5K (5.8%) and ranks #289 of 631 (54th percentile; typical, unremarkable volume). These patterns suggest the practice’s dominant revenue stream is centered on aflibercept and established-patient visits, with other biologics and miscellaneous drug billing at more conventional volumes.

Operational intensity is confirmed by procedural and imaging volumes: 92014 has 3.4K claims and 92134 has 3.5K claims, both producing meaningful revenue ($359.8K and $126.1K respectively) and placing the provider as an extreme outlier or near-extreme outlier in national ranking for these services. High counts of established-patient visits and retinal imaging imply frequent follow-up cycles per patient, consistent with chronic retinal disease management (e.g., AMD, diabetic macular edema) requiring serial injections and OCT monitoring.

Tenure-wise, the provider’s NPI was enumerated on 2007-09-11 (~19 years ago), indicating long-standing Medicare participation. That duration supports the observed high cumulative Medicare revenue and the build-up of procedure volumes and patient follow-up patterns reported in the claims mix.

For payers and network planners, the single-payer Medicare concentration and dominance in key retina codes signal that this provider is a reliable, high-volume source of retina injections and associated imaging/E/M services for Medicare beneficiaries. Given the absence of Medicaid billing, contracting or access strategies that target Medicaid populations would not find this provider active in state-program care based on available files.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	3,640	$690	$2.5M
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	3,390	$110	$359.8K
J2777	Injection, faricimab‑svoa, 0.1 mg	9,120	$30	$264.5K
J3590	Unclassified biologics	100	$2,450	$237.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,950	$110	$220.1K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,500	$40	$126.1K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	490	$160	$77.9K
J2778	Injection, ranibizumab, 0.1 mg	380	$190	$71.1K
J3490	Unclassified drugs	30	$1,770	$49.4K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	170	$220	$35.6K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Maryland Distribution

Gayatri Reilly — 4 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Maryland

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	4	100	950	$690	$887.3K
J2777	32	70	8,520	$30	$487.3K
J2778	40	50	650	$180	$207.8K
J3590	3	20	50	$2,390	$128.9K
67028	27	120	700	$100	$101.5K
Q5128	13	20	200	$210	$78K
J3490	91	100	70	$450	$62.1K
J7312	4	20	270	$160	$53.1K
92014	8	620	210	$90	$44K
67041	6	10	20	$1,060	$30.9K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Gayatri Reilly, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Children's Hospital	DC	Children's Hospital	$0	$243.1M
Children's Hospital	DC	Pediatrics Physician	$0	$115.3M
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Children's Pediatricians & Associates, LLC	MD	Pediatrics Physician	$0	$17.5M
Children's Hospital	NE	Pediatric Emergency Medicine (Pediatrics) Physician	$0	$8.4M
Virginia Oncology Associates	VA	Hematology & Oncology Physician	$0	$6.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Daniel Berinstein	MD	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Alexander Melamud	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0

Nearby Providers

Other providers in the same ZIP code as Gayatri Reilly, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Michael Lai	MD	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Frederick Smith	MD	Medical Oncology Physician	$2.7M	$0
Richard Garfinkel	MD	Retina Specialist (Ophthalmology) Physician	$2.4M	$0
John Schreiber	MD	Diagnostic Radiology Physician	$2.3M	$0
Friendship Ambulatory Surgery Center, LLC	MD	Ambulatory Surgical Clinic/Center	$2.2M	$0
David Weng	MD	Medical Oncology Physician	$1.5M	$0
Hyland Cronin	MD	Dermatology Physician	$1.5M	$0
David Wolfe	MD	Rheumatology Physician	$1.4M	$0
Brian Do	MD	Retina Specialist (Ophthalmology) Physician	$1.2M	$0
Metropolitan Medical Partners LLC	MD	Ambulatory Surgical Clinic/Center	$1.2M	$0

Gayatri Reilly — Billing Profile & Reimbursement Data

Sign up for Gayatri Reilly — Billing Profile & Reimbursement Data policy alerts

Gayatri Reilly — Billing Profile & Reimbursement Data

Sign up for Gayatri Reilly — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References